Buscar resultados de ensayos clínicos
Lung Adenocarcinoma - 26 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar Condición: Advanced Primary Lung Adenocarcinoma Fecha: 2012-03-21 Intervenciones: Drug: endostar Endostar TM 7.5mg/m2,intravenous drip, Day 1to Day 10;Pemetrexed 500mg/m2, intravenous dr |
Recruiting |
Nombre del estudio: A+C in Metastatic Lung Adenocarcinoma Cancer Condición: Lung Adenocarcinoma Metastatic Fecha: 2016-10-24 Intervenciones: Drug: Crizotinib, bevacizumab Eligible patients with ALK translocation or ROS1 translocation or MET ampl |
Not yet recruiting |
Nombre del estudio: Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas Condición: Metastatic Lung Adenocarcinomas Fecha: 2016-08-24 Intervenciones: Other: Non intervention. Observation Study |
Recruiting |
Nombre del estudio: Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma Condición: Lung Adenocarcinoma Fecha: 2016-09-08 Intervenciones: Other: biopsies The biopsies of lung tumour samples will be analysed by immunochemistry (IHC), western b |
Recruiting |
Nombre del estudio: Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas Condición: Stage IV Lung Adenocarcinoma Fecha: 2014-04-21 Intervenciones:
|
Completed |
Nombre del estudio: Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases Condición:
Fecha: 2012-04-11 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR Condición: Adenocarcinoma of Lung Fecha: 2015-07-07 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma Condición: Lung Adenocarcinoma Fecha: 2010-11-24 |
Recruiting |
Nombre del estudio: Tepotinib Phase II Study in Lung Adenocarcinoma Harbouring MET Exon 14 (METex14) Skipping Alterations Condición: Lung Adenocarcinoma Stage IIIB/IV Fecha: 2016-07-29 Intervenciones: Drug: tepotinib Subjects received 500 mg of tepotinib tablet once daily orally during each 21 day cycle |
Recruiting |
Nombre del estudio: Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma Condición: Adenocarcinoma of Lung Fecha: 2016-06-15 Intervenciones:
|